BioSpace News Archive

Job Trends

Foundation Lays Down $250 Million to Expand Pittsburgh Life Sciences Sites

The Richard King Mellon Foundation has awarded a $100 million gift to the University of Pittsburgh and approved a $150 million grant for Carnegie Mellon University.

November 18, 2021
·
2 min read
·
Vanessa Doctor, RN
Business

BridgeBio Gets $750M on Credit to Fuel Long List of Programs

Based on BridgeBio’s current pipeline of programs, this total amount will be sufficient to carry over 30 drug development and discovery programs well into 2024.

November 18, 2021
·
2 min read
·
Vanessa Doctor, RN
Business

Gilead Goes All in On Arcus Option Deal Totaling $725 Million

Gilead Sciences announced it exercised its options to three of Arcus Biosciences’ programs. Two are anti-TIGIT molecules, domvanalimab and AB308, and the other is etrumadenant and quemliclustat.

November 18, 2021
·
3 min read
·
Mark Terry
Genetown

Avrobio’s Small Trials Hint at Cure for 3 Big Lysosomal Diseases

Avrobio’s ex vivo lentiviral gene therapy platform led to durable responses measured in years, and significant reductions in disease-related biomarkers that far exceed today’s standard of care.

November 18, 2021
·
4 min read
·
Gail Dutton
Business

Avilar Debuts to Pioneer Extracellular Protein Degradation

Avilar Therapeutics officially joined the game with $60 million in seed financing from RA Capital Management.

November 18, 2021
·
3 min read
·
Heather McKenzie
Business

BioSpace Movers & Shakers, Nov. 19

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

November 18, 2021
·
9 min read
·
Alex Keown
FDA

COVID-19 Boosters on the Horizon for All Adults, AstraZeneca Antibody Effective

The FDA and CDC will soon decide on Pfizer-BioNTech’s request for an Emergency Use Authorization for the booster shot for their COVID-19 vaccine.

November 18, 2021
·
3 min read
·
Mark Terry
Drug Development

Novartis Investors Champing at the Bit for Action After Roche Stock Sale

Two weeks after Novartis announced it would sell its nearly one-third voting stake in next-door neighbor Roche, investors are chomping at the bit to find out how that almost $21 billion will be put to work.

November 18, 2021
·
3 min read
·
Kate Goodwin
Biotech Bay

Research Roundup: T Helper Cells Post-COVID Vaccine Last At Least 6 Months and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones including T helper cells for COVID-19, new gene found that could contribute to type 1 diabetes and more.

November 18, 2021
·
5 min read
·
Mark Terry
FDA

Monoclonal Antibodies Shine in the Fight Against COVID-19

Monoclonal antibodies have proven to be an important therapeutic option in the ongoing battle against COVID-19.

November 18, 2021
·
4 min read
·
Alex Keown